Longitudinal dynamics of Epstein-Barr virus-specific cytotoxic T lymphocytes during posttransplant lymphoproliferative disorder

被引:27
|
作者
Kuzushima, K
Kimura, H
Hoshino, Y
Yoshimi, A
Tsuge, I
Horibe, K
Morishima, T
Tsurumi, T
Kojima, S
机构
[1] Aichi Canc Ctr, Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi 4648681, Japan
[2] Nagoya Univ, Sch Med, Dept Pediat Dev Pediat, Nagoya, Aichi 466, Japan
[3] Nagoya Univ, Sch Med, Dept Hlth Sci, Nagoya, Aichi 466, Japan
来源
JOURNAL OF INFECTIOUS DISEASES | 2000年 / 182卷 / 03期
基金
日本学术振兴会;
关键词
D O I
10.1086/315791
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epstein-Barr virus (EBV)-associated lymphoproliferative disorder (LPD) is a serious complication after allogeneic bone marrow transplantation (BMT). Dynamics of EBV-specific cytotoxic T lymphocytes (CTL), which are important in controlling EBV during the LPD, have not been fully elucidated A patient with Wiskot-Aldrich's syndrome was diagnosed as suffering from LPD on day 47 after BMT. Fluorescence-activated cell sorter (FACS) analysis for interferon-gamma production revealed that >70% of the patient's CD8(+) T cells were EBV specific. The patient's lymphocytes were directly cytotoxic to donor-derived EBV-positive lymphoblastoid cells, which was blocked by an anti-class I antibody. EBV-specific CD8(+) T cell counts declined in parallel with EBV genome load, and full recovery of LPD was obtained with relaxation of immunosuppressive drags. The results illustrate longitudinal dynamics of EBV-specific CTL during the posttransplant LPD; they also illustrate the advantages of using FAGS analysis for EBV-specific CTL to make decisions about treatment.
引用
收藏
页码:937 / 940
页数:4
相关论文
共 50 条
  • [31] Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients
    Whitney, BM
    Chan, ATC
    Rickinson, AB
    Lee, SP
    Lin, CK
    Johnson, PJ
    JOURNAL OF MEDICAL VIROLOGY, 2002, 67 (03) : 359 - 363
  • [32] Successful in vitro generation of Epstein-Barr virus-specific cytotoxic T lymphocytes from severe chronic active EBV patients
    Hagihara, M
    Tsuchiya, T
    Ueda, Y
    Masui, A
    Gansuvd, B
    Munkhbat, B
    Inoue, H
    Hyodo, O
    Ando, K
    Kato, S
    Hotta, T
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2001, 189 (03) : 137 - 145
  • [33] CD4+ Epstein-Barr virus-specific cytotoxic T-lymphocytes from human umbilical cord blood
    Sun, Q
    Burton, RL
    Pollok, KE
    Emanuel, DJ
    Lucas, KG
    CELLULAR IMMUNOLOGY, 1999, 195 (02) : 81 - 88
  • [34] Autologous Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed nasopharingeal carcinoma
    Comoli, P
    Basso, S
    Schiavo, R
    Moretta, A
    Labirio, M
    Carminati, O
    Del Galdo, F
    De Palma, R
    Siena, S
    Locatelli, F
    Maccario, R
    Pedrazzoli, P
    BONE MARROW TRANSPLANTATION, 2003, 31 : S207 - S207
  • [35] Successful in vitro generation of Epstein-Barr virus-specific cytotoxic T lymphocytes from severe chronic active EBV patients
    Masao Hagihara
    Takahide Tsuchiya
    Yoko Ueda
    Aya Masui
    Bargansuren Gansuvd
    Batmunkh Munkhbat
    Hiroyasu Inoue
    Osamu Hyodo
    Kiyoshi Ando
    Shunichi Kato
    Tomomitsu Hotta
    Medical Microbiology and Immunology, 2001, 189 : 137 - 145
  • [36] Epstein-Barr virus (EBV)-associated posttransplant lymphoproliferative disorder appearing as mandibular gingival ulcers
    Amorim Pellicioli, Ana Carolina
    Luciano, Aline Alves
    Carrinho Ayroza Rangel, Ana Lucia
    de Oliveira, Greison Rabelo
    Santos Silva, Alan Roger
    de Almeida, Oslei Paes
    Vargas, Pablo Agustin
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2016, 121 (04): : E80 - E86
  • [37] EPSTEIN-BARR VIRUS-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER PRESENTING AS PERIRENAL TRANSPLANT LYMPHOCELE
    SQUIERS, EC
    WEST, JC
    LEONARD, D
    LATSHA, R
    MILLER, J
    FETTEROLF, N
    KELLEY, SE
    TYLER, W
    TRANSPLANTATION, 1993, 56 (05) : 1278 - 1279
  • [38] Pretransplant Epstein-Barr Virus Serostatus and Incidence of Posttransplant Lymphoproliferative Disorder in Pediatric Renal Transplants
    Rahimzadeh, Nahid
    Otukesh, Hasan
    Hoseini, Rozita
    Riahifard, Azam
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2013, 11 (04) : 299 - 302
  • [39] Infusions of Epstein-Barr virus-specific cytotoxic T lymphocytes as post-remission therapy in high-risk post-transplant lymphoproliferative disorder patients: report of two cases
    Kim, Nayoun
    Sohn, Hyun-Jung
    Oh, Joo Hyun
    Jeon, Young-Woo
    Lee, Hyun-Joo
    Cho, Hyun-Il
    Chung, Byung Ha
    Yang, Chul-Woo
    Kim, Tai-Gyu
    Cho, Seok-Goo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (05) : 596 - 603
  • [40] Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: A distinct entity?
    Leblond, V
    Davi, F
    Charlotte, F
    Dorent, R
    Bitker, MO
    Sutton, L
    Gandjbakhch, I
    Binet, JL
    Raphael, M
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2052 - 2059